Elixinol (ASX: EXL) will finally be able to sell its CBD products in Australia after penning an exclusive distribution agreement with licenced wholesaler PharmaCann.
Under the agreement PharmaCann will import and supply Elixinol’s branded CBD products into Australia from the US, opening the company up to a brand new market.
“We regularly receive queries about whether our products are accessible in Australia, so we’re very pleased to now be able to offer a solution,” says Elixinol group CEO Oliver Horn.
“The relationship with PharmaCann gives us the ability to see Elixinol branded products in our home market in a way which fits within current regulations.”
As a wholesaler PharmaCann has a wide distribution network into major pharmacy chains including Chemist Warehouse, TerryWhite Chemmart, Priceline Pharmacy, and more.
The company also services more than 1,600 medical practitioners, more than 2,000 pharmacies in Australia and New Zealand and has access to a growing network of more than 130 prescribing doctors.
“At PharmaCann, our ethos is to ensure that all members of our communities have a streamlined access to the most affordable cannabinoid medicines in the market,” says PharmaCann managing director Victor Caprio.
“By working with Elixinol Global to distribute their products in the region, the continuation of our program on delivering affordable, high quality medicines can be met.” [Read more @ Business News Australia]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
LUXEMBOURG is to become the first European country to permit adult-use cannabis after the Government announced measures to permit households to cultivate up to four domestic plants. The announcement, earlier today, applies to to all citizens over the age of 18 with the new regulations also allowing for the sale and import of seeds. However,…
FRIDAY, Oct. 22, 2021 (HealthDay News) — Researchers may be one step closer to developing the equivalent of a Breathalyzer for detecting marijuana use. In an early study, scientists found that their rapid test was able to reliably detect THC in people’s saliva in under 5 minutes. THC, short for tetrahydrocannabinol, is the active ingredient…
New York Labor Law 201-D This document is intended to address some of the most common situations or questions in the workplace related to adult-use cannabis and the Marijuana Regulation and Taxation Act (“MRTA”). This document does not address the medical use of cannabis. For further assistance with New York Labor Law and the MRTA, please…
New York’s Cannabis Control Board issued regulations Thursday to allow medical marijuana users and their caregivers to grow their own supply at home. The proposal, now open to public comment for 60 days, would permit the cultivation of up to six marijuana plants in a private residence. The regulation will take effect after the commentary…